National Health Investors, Inc. (NYSE:NHI) to Issue $0.90 Quarterly Dividend

National Health Investors, Inc. (NYSE:NHI) announced a quarterly dividend on Tuesday, May 7th, Wall Street Journal reports. Shareholders of record on Friday, June 28th will be given a dividend of 0.90 per share by the real estate investment trust on Friday, August 2nd. This represents a $3.60 annualized dividend and a yield of 5.48%. The ex-dividend date of this dividend is Friday, June 28th.

National Health Investors has increased its dividend payment by an average of 0.9% annually over the last three years and has increased its dividend annually for the last 1 consecutive years. National Health Investors has a dividend payout ratio of 119.6% indicating that the company cannot currently cover its dividend with earnings alone and is relying on its balance sheet to cover its dividend payments. Equities research analysts expect National Health Investors to earn $4.53 per share next year, which means the company should continue to be able to cover its $3.60 annual dividend with an expected future payout ratio of 79.5%.

National Health Investors Stock Performance

Shares of NYSE NHI traded up $1.40 during trading on Tuesday, reaching $65.65. 310,620 shares of the company traded hands, compared to its average volume of 170,093. The stock has a market cap of $2.85 billion, a P/E ratio of 20.63 and a beta of 0.95. The firm’s fifty day simple moving average is $60.67 and its 200 day simple moving average is $56.36. The company has a current ratio of 10.27, a quick ratio of 10.27 and a debt-to-equity ratio of 0.90. National Health Investors has a 12-month low of $48.51 and a 12-month high of $66.10.

Insider Buying and Selling

In other news, Director Charlotte A. Swafford bought 10,000 shares of National Health Investors stock in a transaction on Tuesday, February 27th. The stock was acquired at an average price of $58.69 per share, with a total value of $586,900.00. Following the completion of the acquisition, the director now directly owns 110,185 shares of the company’s stock, valued at $6,466,757.65. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 8.21% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on NHI shares. BMO Capital Markets upgraded National Health Investors from a “market perform” rating to an “outperform” rating and set a $67.00 price objective on the stock in a research report on Tuesday, March 12th. StockNews.com downgraded shares of National Health Investors from a “buy” rating to a “hold” rating in a report on Thursday, April 18th. Wells Fargo & Company raised shares of National Health Investors from an “equal weight” rating to an “overweight” rating and lifted their price objective for the company from $55.00 to $63.00 in a report on Monday, February 26th. Wedbush increased their target price on shares of National Health Investors from $64.00 to $66.00 and gave the stock an “outperform” rating in a research note on Monday, March 18th. Finally, Deutsche Bank Aktiengesellschaft began coverage on National Health Investors in a research report on Tuesday, January 30th. They set a “buy” rating and a $69.00 target price on the stock. Five research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $60.50.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.